Telix Pharmaceuticals TLX
NASDAQ TLX
$11.34 -0.28 (-2.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Total Current Liabilities (2023 - 2026)

Updated

Telix Pharmaceuticals (TLX) posted Total Current Liabilities of $242.34 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Total Current Liabilities (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Total Current Liabilities came in at $231.62 million, up 12.9% from the prior year.

  • In prior years, Telix Pharmaceuticals' Total Current Liabilities was $205.09 million in the year ended Dec 31, 2024 (+84.1%) and $111.37 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Telix Pharmaceuticals 3.94 Bn 2.88 Bn - 242.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 242.34 Mn
Dec 31, 2025 231.62 Mn
Dec 31, 2024 216.40 Mn
Dec 31, 2023 107.46 Mn
API Access

Telix Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TLX&period=max&api_key=YOUR_API_KEY